222 related articles for article (PubMed ID: 17115310)
1. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
Gullichsen R
Tech Coloproctol; 2006 Dec; 10(4):346-9. PubMed ID: 17115310
[TBL] [Abstract][Full Text] [Related]
2. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
Van Assche G; Ferrante M; Vermeire S; Noman M; Rans K; Van der Biest L; Penninckx F; Wolthuis A; Rutgeerts P; D'Hoore A
Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
[TBL] [Abstract][Full Text] [Related]
3. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
4. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
5. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy.
Nilubol N; Scherl E; Bub DS; Gorfine SR; Marion J; Harris MT; Kornbluth A; Lichtiger S; Rubin P; George J; Chapman M; Harpaz N; Present D; Bauer JJ
Dis Colon Rectum; 2007 Jun; 50(6):825-31. PubMed ID: 17429711
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
[TBL] [Abstract][Full Text] [Related]
7. Octreotide in the management of diarrhea induced by graft versus host disease.
Ippoliti C; Neumann J
Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
[TBL] [Abstract][Full Text] [Related]
8. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
Rosenoff SH
Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
[TBL] [Abstract][Full Text] [Related]
9. Portal vein thrombi after restorative proctocolectomy: serious complication without long-term sequelae.
Millan M; Hull TL; Hammel J; Remzi F
Dis Colon Rectum; 2007 Oct; 50(10):1540-4. PubMed ID: 17701370
[TBL] [Abstract][Full Text] [Related]
10. Parking the pouch: pouch salvage after anastomotic leak following restorative proctocolectomy. Report of a case.
Maruthachalam K; Kumar R; Hainsworth P
Dis Colon Rectum; 2008 Nov; 51(11):1724-6. PubMed ID: 18484132
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
Penning C; Vecht J; Masclee AA
Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
[TBL] [Abstract][Full Text] [Related]
12. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
Rosenoff S
Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
[TBL] [Abstract][Full Text] [Related]
13. An open trial of octreotide long-acting release in the management of short bowel syndrome.
Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
Morton AJ; Durrant ST
Clin Transplant; 1995 Jun; 9(3 Pt 1):205-8. PubMed ID: 7549062
[TBL] [Abstract][Full Text] [Related]
15. What are the outcomes of reoperative restorative proctocolectomy and ileal pouch-anal anastomosis surgery?
Shawki S; Belizon A; Person B; Weiss EG; Sands DR; Wexner SD
Dis Colon Rectum; 2009 May; 52(5):884-90. PubMed ID: 19502852
[TBL] [Abstract][Full Text] [Related]
16. [Restorative proctocolectomy with an ileoanal pouch. Postoperative course and long-term functional results].
Walker LR; Bülow S
Ugeskr Laeger; 2008 May; 170(20):1721-5. PubMed ID: 18489884
[TBL] [Abstract][Full Text] [Related]
17. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery.
Hait EJ; Bousvaros A; Schuman M; Shamberger RC; Lillehei CW
J Pediatr Surg; 2007 Jan; 42(1):31-4; discussion 34-5. PubMed ID: 17208537
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
Walker JJ; Kaplan DS
Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pouch surgery for ulcerative colitis: single center experience.
El-Raouf AA; Hak NG; Fathy O; El-Ebidy G; Salah T; El-Hemaly M
Hepatogastroenterology; 2008; 55(88):2130-4. PubMed ID: 19260491
[TBL] [Abstract][Full Text] [Related]
20. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
Murao S; Hirata K; Ishida T; Takahara J
Endocr J; 1999 Jun; 46(3):477-8. PubMed ID: 10504003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
